WHO Raises Concerns about Possible Cancer Risk from Aspartame; FDA Disagrees with Findings
In a recent analysis conducted by the World Health Organization (WHO), a potential link between the widely used non-sugar sweetener aspartame and liver cancer has been suggested. However, the Food and Drug Administration (FDA) disputes these findings, asserting that aspartame is safe for consumption under approved conditions.
According to the International Agency for Research on Cancer, a WHO body, there is limited evidence connecting aspartame to hepatocellular carcinoma, a type of liver cancer, based on a review of three extensive human studies. It is important to note that despite this finding, the agency still considers the consumption of aspartame up to 0-40 mg/kg body weight to be acceptable. Aspartame is a common ingredient in various diet sodas, candies, and gums.
Mary Schubauer-Berigan, PhD, a senior official at IARC, emphasized that the analysis should not be interpreted as a definitive statement asserting a known cancer risk associated with aspartame consumption. In our view, this report serves as a call to the research community to further investigate and understand the potential carcinogenic hazard, if any, posed by aspartame consumption, she stated during a press conference.
Contrary to the WHO’s conclusions, the FDA has reviewed the same evidence and raised concerns about the methodology of the studies conducted. A spokesperson from the FDA informed CNBC that aspartame is one of the most extensively studied food additives and that there are no safety concerns when used under approved conditions.
The FDA spokesperson added, FDA scientists do not have safety concerns when aspartame is used under the approved conditions.
The conflicting viewpoints presented by the WHO and the FDA highlight the need for continued research to fully comprehend the potential risks or safety of consuming aspartame.
Aspartame, an artificial sweetener that has faced scrutiny and controversy for years, has undergone rigorous testing to ensure its safety. However, the differing assessments of its potential link to cancer underscore the importance of ongoing scientific investigation to provide a conclusive understanding of its effects.
Consumers should note that regulatory bodies such as the FDA continuously monitor food additives and conduct thorough evaluations to safeguard public health. As of now, the FDA maintains that aspartame is safe for consumption when used within approved guidelines.
While concerns surrounding aspartame’s impact persist, it is crucial to remain mindful of the wealth of scientific research available and to consult with healthcare professionals when making dietary choices.
In conclusion, the recent WHO analysis suggesting a possible link between aspartame and liver cancer has been met with skepticism by the FDA. Both organizations agree that further research is necessary to ascertain any potential health risks associated with the consumption of aspartame. As the scientific community continues to investigate and provide more clarity on this matter, consumers can be reassured by the FDA’s current stance that aspartame is safe under approved conditions.
